TECX earnings: next report 2026-08-06, real EPS beat/miss history, analyst consensus Buy, P/E -7.08. Updated 2026-07-23.
Tectonic Therapeutic (TECX) Research Hub
Tectonic Therapeutic (TECX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 29.05 USD (-4.69%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -7.08, market cap 0.60B. This hub links to the full technical, earnings and options research available for TECX.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 29.05 USD (-4.69%) |
| 52-week range | 27.24 USD – 39.53 USD |
| Trend regime | Range |
| 14-day RSI | 44.5 (Bearish) |
| Trailing P/E | -7.08 |
| Market cap | 0.60B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for TECX
Covered Call on TECX: how it works, illustrative setup around the real 29.05 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on TECX: how it works, illustrative setup around the real 29.05 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on TECX: how it works, illustrative setup around the real 29.05 USD price, max profit/loss, breakeven and when to use it. Educational.
TECX technical analysis: range, last 29.05 USD, RSI 44.5, 52w range 27.24 USD–39.53 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is TECX in?
Tectonic Therapeutic (TECX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is TECX in an uptrend or downtrend?
As of 2026-09-11, TECX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is TECX's trailing P/E ratio?
TECX's trailing P/E is -7.08, with a market cap of 0.60B. See the earnings research page for full valuation detail.
When does TECX next report earnings?
TECX is next scheduled to report earnings on 2026-08-06, with a consensus EPS estimate of -1.34878 USD.